It has been reported that EGFR/ERK/MMP-2 and PTEN/AKT pathways contribute to the development of HCC (Qian et al., 2015; Yang et al., 2020; Wang et al., 2021b). This evidence concerns the gene PTEN and hepatocellular carcinoma.